Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

A safety assessment of crizotinib in the treatment of ALK-positive NSCLC patients.

Dikopf A, Wood K, Salgia R. A safety assessment of crizotinib in the treatment of ALK-positive NSCLC patients. Expert Opin Drug Saf. 2015 Mar; 14(3):485-93.

View in: PubMed

collapse authors with profiles